Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Midgley

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
Bevacizumab--current status and future directionsRachel Midgley, David Kerr
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?David J Kerr, Rachel Midgley
Nature Clinical Practice. Oncology|October 22, 2008
Capecitabine: have we got the dose right?Rachel Midgley, David J Kerr
The New England Journal of Medicine|September 8, 2010
Can we treat cancer for a dollar a day? Guidelines for low-income countriesDavid J Kerr, Rachel Midgley
Nature Clinical Practice. Oncology|August 4, 2005
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!Rachel Midgley, David J Kerr
Digestive Diseases (Basel, Switzerland)|December 5, 2012
Biomarkers in early-stage colorectal cancer: ready for prime time?David Church, Rachel Midgley, David Kerr
Acta Oncologica (Stockholm, Sweden)|August 6, 2003
Colorectal cancerShibani Nicum, Rachel Midgley, David J Kerr
Seminars in Oncology|May 25, 2010
Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liverThinn P Pwint, Rachel Midgley, David J Kerr
Chinese Clinical Oncology|April 6, 2015
Stage II colon cancerDavid N Church, Rachel Midgley, David J Kerr
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Gene profiling in early stage diseaseRachel Midgley, Kakil Rasul, Haitham Al Salama, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
Bevacizumab--current status and future directionsRachel Midgley, David Kerr
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?David J Kerr, Rachel Midgley
Nature Clinical Practice. Oncology|October 22, 2008
Capecitabine: have we got the dose right?Rachel Midgley, David J Kerr
The New England Journal of Medicine|September 8, 2010
Can we treat cancer for a dollar a day? Guidelines for low-income countriesDavid J Kerr, Rachel Midgley
Nature Clinical Practice. Oncology|August 4, 2005
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!Rachel Midgley, David J Kerr
Digestive Diseases (Basel, Switzerland)|December 5, 2012
Biomarkers in early-stage colorectal cancer: ready for prime time?David Church, Rachel Midgley, David Kerr
Acta Oncologica (Stockholm, Sweden)|August 6, 2003
Colorectal cancerShibani Nicum, Rachel Midgley, David J Kerr
Seminars in Oncology|May 25, 2010
Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liverThinn P Pwint, Rachel Midgley, David J Kerr
Chinese Clinical Oncology|April 6, 2015
Stage II colon cancerDavid N Church, Rachel Midgley, David J Kerr
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Gene profiling in early stage diseaseRachel Midgley, Kakil Rasul, Haitham Al Salama, et al.
Pageof 3